Original Article

You have full text access to this OnlineOpen article

Impact of aging on the development of hepatocellular carcinoma in patients with posttransfusion chronic hepatitis C

  1. Hisayuki Hamada M.D.1,2,
  2. Hiroshi Yatsuhashi M.D.1,†,*,
  3. Koji Yano M.D.1,
  4. Manabu Daikoku M.D.1,
  5. Kokichi Arisawa M.D.3,
  6. Osami Inoue M.D.1,
  7. Michiaki Koga M.D.1,
  8. Keisuke Nakata M.D.2,
  9. Katsumi Eguchi M.D.2,
  10. Michitami Yano M.D.1

Article first published online: 11 JUL 2002

DOI: 10.1002/cncr.10662

Issue

Cancer

Cancer

Volume 95, Issue 2, pages 331–339, 15 July 2002

Additional Information

How to Cite

Hamada, H., Yatsuhashi, H., Yano, K., Daikoku, M., Arisawa, K., Inoue, O., Koga, M., Nakata, K., Eguchi, K. and Yano, M. (2002), Impact of aging on the development of hepatocellular carcinoma in patients with posttransfusion chronic hepatitis C. Cancer, 95: 331–339. doi: 10.1002/cncr.10662

Author Information

  1. 1

    Institute for Clinical Research, World Health Organization Collaborating Center for Reference and Research on Viral Hepatitis, National Nagasaki Medical Center, Nagasaki, Japan

  2. 2

    The First Department of Internal Medicine, Nagasaki University School of Medicine, Nagasaki, Japan

  3. 3

    Department of Preventive Medicine and Health Promotion, Nagasaki University School of Medicine, Nagasaki, Japan

  1. †

    Fax: (011) +81-957-53-6675

*Institute for Clinical Research, World Health Organization Collaborating Center for Reference and Research on Viral Hepatitis, National Nagasaki Medical Center, Kubara 2-1001-1, Omura 852-8562, Nagasaki, Japan

Publication History

  1. Issue published online: 11 JUL 2002
  2. Article first published online: 11 JUL 2002
  3. Manuscript Accepted: 19 FEB 2002
  4. Manuscript Revised: 11 FEB 2002
  5. Manuscript Received: 15 OCT 2001

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (104K)

REFERENCES

  • 1
    Di Bisceglie AM. Natural history of hepatitis C: its impact on clinical management. Hepatology. 2000; 31: 1014–1018.
    Direct Link:
  • 2
    Alberti A, Chemello L, Benvegn L. Natural history of hepatitis C. J Hepatol. 1999; 31 (Suppl 1): 17–24.
  • 3
    Tremolada F, Casarin C, Alberti A, et al. Long-term follow-up of non-A, non-B (type C) post-transfusion hepatitis. J Hepatol. 1992; 16: 273–281.
  • 4
    Alter MJ, Kruszon Moran D, Nainan OV, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med. 1999; 341: 556–562.
  • 5
    Kiyosawa K, Sodeyama T, Tanaka E, et al. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody of hepatitis C virus. Hepatology. 1990; 12(4 Pt 1): 671–675.
    Direct Link:
  • 6
    Serfaty L, Aumaitre H, Chazouilleres C, et al. Determinants of outcome of compensated hepatitis C virus- related cirrhosis. Hepatology. 1998; 27: 1435–1440.
    Direct Link:
  • 7
    Yatsuhashi H, Yano M. Towards control of hepatitis C in the Asia-Pacific region. J Gastroenterol Hepatol. 2000; 15 (Suppl): E111–E116.
  • 8
    Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology. 1994; 19: 1513–1520.
    Direct Link:
  • 9
    Tong MJ, el Farra NS, Reikes AR, Co RL. Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med. 1995; 332: 1463–1466.
  • 10
    Ikeda K, Saitoh S, Koida I, et al. A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with iral and alcoholic cirrhosis. Hepatology. 1993; 18: 47–53.
    Direct Link:
  • 11
    Ikeda K, Saitoh S, Suzuki Y, et al. Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis: a prospective observation of 2215 patients. J Hepatol. 1998; 28: 930–938.
  • 12
    Takano S, Yokosuka O, Imazeki F, Tagawa M, Omata M. Incidence of hepatocellular carcinoma in chronic hepatitis B and C: a prospective study of 251 patients. Hepatology. 1995; 21: 650–655.
    Direct Link:
  • 13
    Aizawa Y, Shibamoto Y, Takagi I, Zeniya M, Toda G. Analysis of factors affecting the appearance of hepatocellular carcinoma in patients with chronic hepatitis C. A long term follow-up study after histologic diagnosis. Cancer. 2000; 89: 53–59.
  • 14
    Hu KQ, Tong MJ. The long-term outcomes of patients with compensated hepatitis C virus-related cirrhosis and history of parenteral exposure in the United States. Hepatology 1999; 29: 1311–1316.
    Direct Link:
  • 15
    Khan MH, Farrell GC, Byth K, et al. Which patients with hepatitis C develop liver complications? Hepatology. 2000; 31: 513–520.
    Direct Link:
  • 16
    Nishiguchi S, Kuroki T, Nakatani S, et al. Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis. Lancet. 1995; 346: 1051–1055.
  • 17
    Wiley TE, McCarthy M, Breidi L, McCarthy M, Layden TJ. Impact of alcohol on the histological and clinical progression of hepatitis C infection. Hepatology. 1998; 28: 805–809.
    Direct Link:
  • 18
    Corrao G, Aric S. Independent and combined action of hepatitis C virus infection and alcohol consumption on the risk of symptomatic liver cirrhosis. Hepatology. 1998; 27: 914–919.
    Direct Link:
  • 19
    Niederau C, Lange S, Heintges T, et al. Prognosis of chronic hepatitis C: results of a large, prospective cohort study. Hepatology. 1998; 28: 1687–1695.
    Direct Link:
  • 20
    Yano M, Yatsuhashi H, Inoue O, Inokuchi K, Koga M. Epidemiology and long term prognosis of hepatitis C virus infection in Japan. Gut. 1993; 34 (2 Suppl): S13–S16.
  • 21
    Kasahara A, Hayashi N, Mochizuki K, et al. Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C. Osaka Liver Disease Study Group. Hepatology. 1998; 27: 1394–1402.
    Direct Link:
  • 22
    Yano M, Kumada H, Kage M, et al. The long-term pathological evolution of chronic hepatitis C. Hepatology. 1996; 23: 1334–1340.
    Direct Link:
  • 23
    Kobayashi M, Tnanaka E, Sodeyama T, Urushihara A, Matsumoto A, Kiyosawa K. The natural course of chronic hepatitis C: a comparison between patients with genotypes 1 and 2 hepatitis C viruses. Hepatology. 1996; 23: 695–699.
    Direct Link:
  • 24
    Schoniger-Hekele M, Muller C, Kutilek M, Oesterricher C, Ferenci P, Gangl A. Hepatocellular carcinoma in Austria: aetiological and clinical characteristics at presentation. Eur J Gastroenterol Hepatol. 2000; 12: 941–948.
  • 25
    Shiratori Y, Shiina S, Imamura M, et al. Characteristic difference of hepatocellular carcinoma between hepatitis B- and C- viral infection in Japan. Hepatology. 1995; 22(4 Pt 1): 1027–1033.
    Direct Link:
  • 26
    Shimauchi Y, Tanaka M, Koga K, et al. Clinical characteristics of patients in their 40s with HCV antibody-positive hepatocellular carcinoma. Alcohol Clin Exp Res. 2000; 24: 64s–67s.
  • 27
    Noda K, Yoshihara H, Suzuki K, et al. Progression of type C chronic hepatitis to liver cirrhosis and hepatocellular carcinoma: its relationship to alcohol drinking and the age of transfusion. Alcohol Clin Exp Res. 1996; 20: 95A–100A.
    Direct Link:
  • 28
    Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet. 1997; 349: 825–832.
  • 29
    Balducci L, Extermann M. Management of cancer in the older person: a practical approach. Oncologist. 2000; 5: 224–237.
  • 30
    Goukassian D, Gad F, Yaar M, Eller MS, Nehal US, Gilchrest BA. Mechanisms and implications of the age-associated decrease in DNA repair capacity. FASEB J. 2000; 14: 1325–1324.
View Full Article (HTML) Get PDF (104K)